Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine
Clinical trial NCT00466245 · COMPLETED
Trial details
- NCT number
- NCT00466245
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-06-01
- Enrollment
- 590
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.